Hyperion Therapeutics
Amgen Completes Acquisition of Horizon Therapeutics.
Launch date
Market cap
-
Enterprise valuation
CAD1.5b (Public information from Mar 2015)
Dublin County Dublin (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
N/A | Series A | ||
| N/A | $15.0m | Debt | |
$60.0m | Series C | ||
| N/A | $17.5m | Late VC | |
| N/A | $7.5m | Debt | |
| N/A | N/A | IPO | |
* | N/A | $59.7m | Post IPO Equity |
$1.1b Valuation: $1.1b | Acquisition | ||
| Total Funding | CAD106m | ||